Surgical Hemostasis

Also known as: Maintenance of surgical hemostasis therapy / Maintenance of surgical hemostasis / Hemostasis, Surgical / Hemostasis,Surgical / Surgical haemostasis / Haemostasis / Hemostasis

Drug	Drug Name	Drug Description
DB09222	Fibrinogen human	A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
DB11571	Human thrombin	A platelet activating factor used to treat minor bleeding.

Drug	Drug Name	Target	Type
DB11571	Human thrombin	Coagulation factor V	target
DB11571	Human thrombin	Coagulation factor VIII	target
DB11571	Human thrombin	Coagulation factor XI	target
DB11571	Human thrombin	Coagulation factor XIII A chain	target
DB11571	Human thrombin	Coagulation factor XIII B chain	target
DB11571	Human thrombin	Fibrinogen alpha chain	target
DB11571	Human thrombin	Fibrinogen beta chain	target
DB11571	Human thrombin	Fibrinogen gamma chain	target

Drug	Drug Name	Phase	Status	Count
DB04923	rhThrombin	2	Completed	1
DB11571	Human thrombin	3	Completed	1
DB11300	Thrombin	3	Completed	1
DB04923	rhThrombin	3	Completed	2
DB00016	Erythropoietin	4	Terminated	1